Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Muzi

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2018
Test-Retest Reproducibility of <sup>18</sup>F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local NetworkBrenda F Kurland, Lanell M Peterson, Andrew T Shields, et al.
Mathematical Medicine and Biology : a Journal of the IMA|May 13, 2011
Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET imagesStanley Gu, Gargi Chakraborty, Kyle Champley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptakeLisa K Dunnwald, Robert K Doot, Jennifer M Specht, et al.
Scientific Reports|April 8, 2021
Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and <sup>18</sup>F-FMISO PETShiliang Huang, Joel E Michalek, David A Reardon, et al.
Molecular Imaging and Biology|May 14, 2025
[18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast CancerPoorni M Manohar, Lanell M Peterson, Isaac C Jenkins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2018
Prospective Study of Serial <sup>18</sup>F-FDG PET and <sup>18</sup>F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast CancerLanell M Peterson, Janet O'Sullivan, Qian Vicky Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 31, 2015
Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687Evan Y Yu, Fenghai Duan, Mark Muzi, et al.
Breast Cancer Research : BCR|August 24, 2021
<sup>18</sup>F-fluorodeoxyglucose (FDG) PET or <sup>18</sup>F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity studyPerrin E Romine, Lanell M Peterson, Brenda F Kurland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survivalAlexander M Spence, Mark Muzi, Kristin R Swanson, et al.
Tomography (Ann Arbor, Mich.)|February 24, 2023
Evaluation of Apparent Diffusion Coefficient Repeatability and Reproducibility for Preclinical MRIs Using Standardized Procedures and a Diffusion-Weighted Imaging PhantomDariya Malyarenko, Ghoncheh Amouzandeh, Stephen Pickup, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2018
Test-Retest Reproducibility of <sup>18</sup>F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local NetworkBrenda F Kurland, Lanell M Peterson, Andrew T Shields, et al.
Mathematical Medicine and Biology : a Journal of the IMA|May 13, 2011
Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET imagesStanley Gu, Gargi Chakraborty, Kyle Champley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptakeLisa K Dunnwald, Robert K Doot, Jennifer M Specht, et al.
Scientific Reports|April 8, 2021
Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and <sup>18</sup>F-FMISO PETShiliang Huang, Joel E Michalek, David A Reardon, et al.
Molecular Imaging and Biology|May 14, 2025
[18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast CancerPoorni M Manohar, Lanell M Peterson, Isaac C Jenkins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2018
Prospective Study of Serial <sup>18</sup>F-FDG PET and <sup>18</sup>F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast CancerLanell M Peterson, Janet O'Sullivan, Qian Vicky Wu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 31, 2015
Castration-resistant prostate cancer bone metastasis response measured by 18F-fluoride PET after treatment with dasatinib and correlation with progression-free survival: results from American College of Radiology Imaging Network 6687Evan Y Yu, Fenghai Duan, Mark Muzi, et al.
Breast Cancer Research : BCR|August 24, 2021
<sup>18</sup>F-fluorodeoxyglucose (FDG) PET or <sup>18</sup>F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity studyPerrin E Romine, Lanell M Peterson, Brenda F Kurland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survivalAlexander M Spence, Mark Muzi, Kristin R Swanson, et al.
Tomography (Ann Arbor, Mich.)|February 24, 2023
Evaluation of Apparent Diffusion Coefficient Repeatability and Reproducibility for Preclinical MRIs Using Standardized Procedures and a Diffusion-Weighted Imaging PhantomDariya Malyarenko, Ghoncheh Amouzandeh, Stephen Pickup, et al.
Pageof 9